Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3633430 | 0.91 | ALDH1A1 (0.54) | MAPK1ALDH1A1HPGDMAPTGAA | |
| SCHEMBL1644885 | 0.86 | MAPK1 (0.59) | MAPK1ALDH1A1HPGDMAPTGAA | |
| SCHEMBL3150784 | 0.86 | ALDH1A1 (0.59) | MAPK1ALDH1A1HPGDTSHRPOLB | |
| SCHEMBL7055476 | 0.86 | ALDH1A1 (0.57) | MAPK1ALDH1A1HPGDTSHRPOLB | |
| SCHEMBL30168125 | 0.86 | ALDH1A1 (0.59) | MAPK1ALDH1A1HPGDTSHRPOLB | |
| SCHEMBL9717979 | 0.85 | HTT (0.72) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL2349955 | 0.85 | MAPT (0.61) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL29580443 | 0.85 | HTT (0.72) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL948318 | 0.85 | MAPT (0.59) | ALDH1A1HPGDMAPTGAAPOLB | |
| SCHEMBL7236261 | 0.84 | ALDH1A1 (0.55) | MAPK1ALDH1A1HPGDTSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106518828-B | Amides myricetin derivative, preparation method and application | 贵州大学 | 2018-10-23 | — | — | CN | claimed |
| CN-106518828-A | Amides myricetin derivative and preparation method and application thereof | 贵州大学 | 2017-03-22 | — | — | CN | claimed |
| JP-4665239-B2 | — | — | 2011-04-06 | — | — | JP | claimed |
| CN-1088992-C | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | ALCON LAB INC (US) | 2002-08-14 | — | — | CN | claimed |
| JP-2002512230-A | — | — | 2002-04-23 | — | — | JP | claimed |
| EP-1071668-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | Du Pont Pharmaceuticals Company (US) | 2001-01-31 | — | — | EP | claimed |
| WO-1999054308-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-10-28 | — | — | WO | claimed |
| CN-1129397-A | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | ALCON LAB INC (US) | 1996-08-21 | — | — | CN | claimed |
| US-20240239934-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240239934-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| CN-117886701-A | Full-continuous preparation method of 4-nitrophenethylamine | 爱斯特（成都）生物制药股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230381327-A1 | REACTIVE CONJUGATES | DEBIOPHARM RESEARCH & MANUFACTURING S.A. (CH) | 2023-11-30 | — | — | US | disclosed |
| US-20230250086-A1 | METHIONINE METABOLIC PATHWAY INHIBITORS | MIGAL - GALILEE RESEARCH INSTITUTE LTD. (IL) | 2023-08-10 | — | — | US | disclosed |
| US-20230234967-A1 | Fused Azole Heterocycles as AHR Antagonists | SAIL BIOMEDICINES, INC. | 2023-07-27 | — | — | US | disclosed |
| EP-0970954-A1 | 3-PIPERIDYL-4-OXOQUINAZOLINE DERIVATIVES AND MEDICINCAL COMPOSITIONS CONTAINING THE SAME | JAPAN TOBACCO INC. (JP) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999054308-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-10-28 | — | — | WO | disclosed |
| CN-1129397-A | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | ALCON LAB INC (US) | 1996-08-21 | — | — | CN | disclosed |
| US-5422211-A | Imaging members with trisazo photogenerating materials | XEROX CORPORATION (US) | 1995-06-06 | — | — | US | disclosed |
| EP-0593251-A1 | Process for the catalytic debromination of halogenated monocyclic aromatic compounds | HOECHST CELANESE CORPORATION (US) | 1994-04-20 | — | — | EP | disclosed |
| WO-1994001394-A1 | PREPARATION OF N-ARYL AMIDES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1994-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234967-A1 | Fused Azole Heterocycles as AHR Antagonists | AHR, ARNT, AIPL1 | MAPK1 1346/4885ALDH1A1 799/4885HPGD 148/4885 |
| US-20230250086-A1 | METHIONINE METABOLIC PATHWAY INHIBITORS | GSS, MTR, CTH | MAPK1 1228/4885ALDH1A1 757/4885HPGD 1679/4885 |
| US-20230381327-A1 | REACTIVE CONJUGATES | FCGR3B, FCGR1A, FCGR2A | MAPK1 2065/4885ALDH1A1 638/4885HPGD 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.